top of page
Search


FDA Finalizes Human Factors Submission Guidance: Key Changes from the 2022 Draft
On May 29, 2026, the FDA issued the final guidance on human factors information in medical device marketing submissions to CDRH. The guidance introduces several notable changes from the 2022 draft, including describing a new risk-based decision framework that may reduce the need for human factors validation testing for some devices. LHF's Senior HF Engineer Hannah Cutright highlights the most significant updates and what they mean for device manufacturers preparing FDA submis
Hannah Cutright
Jun 184 min read


“But the Benefits Outweigh the Risks”
"The benefits outweigh the risk" is a frequently used justification by medical and combination device manufacturers to bring new devices to the market. However, is this justification good enough? Human Factors (HF) professionals, Beth Loring and Hollie Johnston, weigh in on the value of going above and beyond the minimum regulatory requirements to develop devices that are not just safe, but also successful and delightful to use.
Beth Loring
Aug 11, 20254 min read


FDA Draft Guidance on Predetermined Change Control Plans: Implications for Medical Device Manufacturers
Read about the FDA's new guidance, which details how medical device manufacturers can include pre-planned modifications in their submission.
Laurie Reed
Sep 11, 20245 min read


Conducting an Aseptic Presentation Study
At the 2024 HFES (International Human Factors Symposium), Laurie and Jan shared key usability study design considerations for evaluating medical devices with sterile barrier packaging systems (SBS).
Laurie Reed
Mar 22, 20245 min read
bottom of page
